Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Replicel Life Sciences Inc
V.RP
Alternate Symbol(s):
REPCF
Technology
Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair...
restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jul 13, 2022 12:33pm
RE:RE:RE:Replicel Twitter 13.07.2022
Metzger always the optomist but that is good. Always good to have believers. I am unfortunately not so optomistic. We have heard many promising tweets and NR's from Replicel over the
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Jul 13, 2022 12:03pm
RE:RE:Replicel Twitter 13.07.2022
Timeline for the Dermaprecise submission for FDA Approval: Possibly Status of the Shiseido Arbitration (3 months to deadline): the biggest Hope of us is the Shiseido Arbitration because it
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jul 13, 2022 11:08am
RE:Replicel Twitter 13.07.2022
Yes indeed we do deserve the updates (plural). I guess we will be seeing more than one all encompassing update. What will these updates cover ? Let's hope it includes: Timeline for the
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Post by
MetzGER
on Jul 13, 2022 1:12am
Replicel Twitter 13.07.2022
We recognize we've been very quiet lately. We know we're past due for some updates. We have been working hard to get our financials updated and compliant. Now we are working hard to get you
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Post by
MetzGER
on Jul 11, 2022 8:08am
Replicel terminated Shiseido's license 21.12.2021
"We have now terminated Shiseido's license to RCH-01. In the context of our arbitration, this provides RepliCel with the widest array of remedies including damages, return of license, etc
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Jul 09, 2022 3:35am
RE:RE:RE:RE:Private Placement
They will Go pur of Cash because Lee needs his 240.000$ salary For doing nothing
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jul 08, 2022 6:40pm
RE:RE:RE:Private Placement
Well no matter what, we should hear back on the conclusion of the arbitration with Shiseido by mid-Oct. that will be here before we know it. But this is bad news, they will run out of cash at this
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jul 08, 2022 12:45pm
RE:RE:Private Placement
The only one willing to buy millions of shares at this point is Andrew Schutte. This PP was a desperate plea for some working capital to kick the can down the road a little further. At the
...more
(1)
•••
toniZ1
X
View Profile
View Bullboard History
Comment by
toniZ1
on Jul 08, 2022 11:48am
RE:Private Placement
indeed, no good news. But you can't say that if someone is willing to buy for some millions dollars shares he could do that for 0,10 at the stock market. Such a order would never be filled and if
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jul 07, 2022 9:56am
Private Placement
From Stockwatch today: "RepliCel Life Sciences Inc. does not intend to complete the second tranche of its non-brokered private placement"... This is not good news. Obviously no takers
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jul 05, 2022 11:06am
RE:RE:MCTO vs Private Placement
Amen! Not holding my breath...I'm sure Lee will spin his words to evade anything concrete. He will say a lot without saying anything at all
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jul 05, 2022 10:40am
RE:MCTO vs Private Placement
Now that the MCTO has been lifted and we are 2 days away from the PP closing it is time for management to give us a detailed update on what is really going on with the company. Questions: Did
...more
(2)
•••
ZeoGak
X
View Profile
View Bullboard History
Post by
ZeoGak
on Jul 02, 2022 2:26pm
FWIW: Rogaine Shortage NYC
https://nypost.com/2022/07/02/new-york-city-in-grips-of-rogaine-shortage/
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Jul 01, 2022 11:43am
RE:RE:RE:Annual report
Now i am interested How the private Placement Ends :)
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >